Requirement of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite: possible involvement of S-nitrosothiols - PubMed (original) (raw)
Requirement of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite: possible involvement of S-nitrosothiols
L J Ignarro et al. Biochim Biophys Acta. 1980.
Abstract
Glyceryl trinitrate specifically required cysteine, whereas NaNO2 at concentrations less than 10 mM required one of several thiols or ascorbate, to activate soluble guanylate cyclase from bovine coronary artery. However, guanylate cyclase activation by nitroprusside or nitric oxide did not require the addition of thiols or ascorbate. Whereas various thiols enhanced activation by nitroprusside, none of the thiols tested enhanced activation by nitric oxide. S-Nitrosocysteine, which is formed when cysteine reacts with either NO-2 or nitric oxide, was a potent activator of guanylate cyclase. Similarly, micromolar concentrations of the S-nitroso derivatives of penicillamine, GSH and dithiothreitol, prepared by reacting the thiol with nitric oxide, activated guanylate cyclase. Guanylate cyclase activation by S-nitrosothiols resembled that by nitric oxide and nitroprusside in that activation was inhibited by methemoglobin, ferricyanide and methylene blue. Similarly, guanylate cyclase activation by glyceryl trinitrae plus cysteine, and by NaNO2 plus either a thiol or ascorbate, was inhibited by methemoglobin, ferricyanide and methylene blue. These data suggest that the activation of guanylate cyclase by each of the compounds tested may occur through a common mechanism, perhaps involving nitric oxide. Moreover, these findings suggest that S-nitrosothiols could act as intermediates in the activation of guanylate cyclase by glyceryl trinitrate, NaNO2 and possibly nitroprusside.
Similar articles
- Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite.
Gruetter CA, Kadowitz PJ, Ignarro LJ. Gruetter CA, et al. Can J Physiol Pharmacol. 1981 Feb;59(2):150-6. doi: 10.1139/y81-025. Can J Physiol Pharmacol. 1981. PMID: 6112057 - Comparative effects of activation of soluble and particulate guanylyl cyclase on cyclic GMP elevation and relaxation of bovine tracheal smooth muscle.
Ijioma SC, Challiss RA, Boyle JP. Ijioma SC, et al. Br J Pharmacol. 1995 Jul;115(5):723-32. doi: 10.1111/j.1476-5381.1995.tb14993.x. Br J Pharmacol. 1995. PMID: 8548169 Free PMC article. - Stimulation of soluble coronary arterial guanylate cyclase by SIN-1.
Schmidt K, Kukovetz WR. Schmidt K, et al. Eur J Pharmacol. 1986 Mar 11;122(1):75-9. doi: 10.1016/0014-2999(86)90160-3. Eur J Pharmacol. 1986. PMID: 2869962 - How does ascorbic acid prevent endothelial dysfunction?
May JM. May JM. Free Radic Biol Med. 2000 May 1;28(9):1421-9. doi: 10.1016/s0891-5849(00)00269-0. Free Radic Biol Med. 2000. PMID: 10924860 Review. - Direct vasodilators with unknown modes of action: the nitro-compounds and hydralazine.
Kreye VA. Kreye VA. J Cardiovasc Pharmacol. 1984;6 Suppl 4:S646-55. doi: 10.1097/00005344-198406004-00011. J Cardiovasc Pharmacol. 1984. PMID: 6083407 Review.
Cited by
- Contribution of aldehyde dehydrogenase to mitochondrial bioactivation of nitroglycerin: evidence for the activation of purified soluble guanylate cyclase through direct formation of nitric oxide.
Kollau A, Hofer A, Russwurm M, Koesling D, Keung WM, Schmidt K, Brunner F, Mayer B. Kollau A, et al. Biochem J. 2005 Feb 1;385(Pt 3):769-77. doi: 10.1042/BJ20041354. Biochem J. 2005. PMID: 15377279 Free PMC article. - Effects of nitroglycerin/L-cysteine on soluble guanylate cyclase: evidence for an activation/inactivation equilibrium controlled by nitric oxide binding and haem oxidation.
Gorren AC, Russwurm M, Kollau A, Koesling D, Schmidt K, Mayer B. Gorren AC, et al. Biochem J. 2005 Sep 1;390(Pt 2):625-31. doi: 10.1042/BJ20050565. Biochem J. 2005. PMID: 15907191 Free PMC article. - The enzymatic function of the honorary enzyme: S-nitrosylation of hemoglobin in physiology and medicine.
Premont RT, Singel DJ, Stamler JS. Premont RT, et al. Mol Aspects Med. 2022 Apr;84:101056. doi: 10.1016/j.mam.2021.101056. Epub 2021 Nov 28. Mol Aspects Med. 2022. PMID: 34852941 Free PMC article. Review. - Preparation, Antioxidant Properties and Ability to Increase Intracellular NO of a New Pyridoxine Derivative B6NO.
Balakina A, Prikhodchenko T, Amozova V, Stupina T, Mumyatova V, Neganova M, Yakushev I, Kornev A, Gadomsky S, Fedorov B, Mishchenko D. Balakina A, et al. Antioxidants (Basel). 2021 Sep 13;10(9):1451. doi: 10.3390/antiox10091451. Antioxidants (Basel). 2021. PMID: 34573083 Free PMC article. - Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver.
Duranski MR, Greer JJ, Dejam A, Jaganmohan S, Hogg N, Langston W, Patel RP, Yet SF, Wang X, Kevil CG, Gladwin MT, Lefer DJ. Duranski MR, et al. J Clin Invest. 2005 May;115(5):1232-40. doi: 10.1172/JCI22493. Epub 2005 Apr 14. J Clin Invest. 2005. PMID: 15841216 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources